Cargando…

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a common malignant tumor of which the occurrence and development, the tumorigenicity of HCC is involving in multistep and multifactor interactions. Interleukin-6 (IL-6), a multifunctional inflammatory cytokine, has increased expression in HCC patients and is closely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Junnv, Lin, Haifeng, Wu, Gang, Zhu, Mingyue, Li, Mengsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714735/ https://www.ncbi.nlm.nih.gov/pubmed/34976809 http://dx.doi.org/10.3389/fonc.2021.760971

Ejemplares similares

Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells
por: Feng, Haipeng, et al.
Publicado: (2020)

AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers
por: Lin, Bo, et al.
Publicado: (2021)

Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
por: Lin, Bo, et al.
Publicado: (2021)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
por: Zhang, Minni, et al.
Publicado: (2023)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment
por: He, Ke, et al.
Publicado: (2020)

α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis
por: Wang, Qiujiao, et al.
Publicado: (2022)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
por: Xia, Haoming, et al.
Publicado: (2021)

IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
por: Li, Yu, et al.
Publicado: (2020)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019)

Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Sun, Wan, et al.
Publicado: (2021)

The IL-6/STAT3 Signaling Pathway Is an Early Target of Manuka Honey-Induced Suppression of Human Breast Cancer Cells
por: Aryappalli, Priyanka, et al.
Publicado: (2017)

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
por: Manore, Sara G., et al.
Publicado: (2022)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

Benzyl-isothiocyanate Induces Apoptosis and Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells in vitro
por: Zhu, Mingyue, et al.
Publicado: (2017)

lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma
por: Zhu, Xuewei, et al.
Publicado: (2021)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity
por: Wang, Wenting, et al.
Publicado: (2019)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012)

Aurora-A Kinase as a Promising Therapeutic Target in Cancer
por: D’Assoro, Antonino B., et al.
Publicado: (2016)

Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer
por: Nuñez-Olvera, Stephanie I., et al.
Publicado: (2019)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
por: Xu, Jinghang, et al.
Publicado: (2020)

Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target
por: Yao, Renzhi, et al.
Publicado: (2018)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
por: Lu, Yan, et al.
Publicado: (2016)

Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
por: Zhu, Mingyue, et al.
Publicado: (2016)

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma
por: Chen, Qianhui, et al.
Publicado: (2022)

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
por: Gu, Fang-Ming, et al.
Publicado: (2011)

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
por: Ouyang, Xiaoxi, et al.
Publicado: (2022)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
por: Liu, Gang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_app7tkg14jn8jm0k7u2vh8q6g5